Newsbenzinga
Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning
· Published
Article summary
Quest Diagnostics (NYSE: DGX) stock jumps after Q2 earnings beat estimates and full-year 2026 guidance gets a boost.
An excerpt from the original article.
Comments —
Loading comments…